CIK 0001798749
- Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831377888
- Phone
- +1 781-312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-27 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −11,068 | $27.97 | $310K | 1,291 |
| 2024-03-27 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,068 | 29,000 | ||
| 2024-03-25 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +3,432 | $10.61 | $36K | 4,723 |
| 2024-03-25 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −3,432 | $28.01 | $96K | 1,291 |
| 2024-03-25 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,432 | 40,068 | ||
| 2024-03-19 | Verwijs Marinus CHIEF TECHNICAL OFFICER | Option exercise 10b5-1 | +5,300 | $14.59 | $77K | 5,300 |
| 2024-03-19 | Verwijs Marinus CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −2,536 | $25.68 | $65K | 2,764 |
| 2024-03-19 | Verwijs Marinus CHIEF TECHNICAL OFFICER | Sale 10b5-1 | −2,764 | $26.46 | $73K | 0 |
| 2024-03-19 | Verwijs Marinus CHIEF TECHNICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,300 | 84,700 | ||
| 2024-03-18 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +4,000 | $1.74 | $7K | 7,251 |
| 2024-03-18 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +3,000 | $2.14 | $6K | 10,251 |
| 2024-03-18 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −6,387 | $25.81 | $165K | 3,864 |
| 2024-03-18 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −613 | $26.40 | $16K | 3,251 |
| 2024-03-18 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,000 | 4,036 | ||
| 2024-03-18 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,000 | 98,510 | ||
| 2024-03-18 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +20,557 | $2.14 | $44K | 21,848 |
| 2024-03-18 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +14,500 | $10.61 | $154K | 36,348 |
| 2024-03-18 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −27,476 | $25.74 | $707K | 8,872 |
| 2024-03-18 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −7,581 | $26.48 | $201K | 1,291 |
| 2024-03-18 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,557 | 102,789 |
Page 6 of 16 · 315 trades